Leaderboard

En | De
No articles selected!     View Cart  
You are here: Oncology » Urologic Neoplasms 14. August 2026
Search
medline.ch
Urologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 9037  Previews Next
   
   Articles 1 - 20 / 180724  
   
Efficacy of Nivolumab in Chemotherapy-Resistant Mesothelioma of the Tunica Vaginalis Testis: A Case Report.
Cancer Rep (Hoboken)
Koyanagi H, Kawahara T, Inagawa N, Shiga M, Sakurai H, Yamaguchi A, Tanuma K, Nitta S, Kojo K, Shiga M, Nagumo Y, Ikeda A, Kandori S, Hoshi A, Negoro H, Kawai H, Matsubara D, Nishiyama H.
PMID: 42598890 [PubMed - indexed for MEDLINE]


Sequential Enzalutamide-Docetaxel Versus Abiraterone-Docetaxel Therapy in Castration-Resistant Prostate Cancer: A Subanalysis of the ENABLE Study.
Int J Urol
Kamiyama M, Izumi K, Mitsui T, Shima T, Kato Y, Mita K, Okamura T, Inoue S, Hoshi S, Tanaka N, Yoshio Y, Tatarano S, Chikazawa I, Kawai N, Hashimoto K, Fukagai T, Shigehara K, Takahara S, Mizokami A.
PMID: 42598868 [PubMed - indexed for MEDLINE]


From fusion partner to clinical practice: A treatment-oriented framework for transcription factor E3 (TFE3)-rearranged renal carcinoma.
Cancer Pathog Ther
Man J, Wang K, Zhang Y, Wang H, Yang L.
PMID: 42598106 [PubMed]


Preliminary study on the efficacy of pazopanib combined with toripalimab as first-line therapy for metastatic renal cell carcinoma: Real-world data from a single center.
Oncol Lett
Wang B, Xing T, Liu H, Han X, Wu K.
PMID: 42597921 [PubMed]


Nanoplatform-Mediated Remodeling of the Immune Microenvironment in Renal Cell Carcinoma.
Int J Nanomedicine
Luo M, Tang P, Chen X, Lan W, Tang S, Liu Q, Zhou L, Huang Y.
PMID: 42597677 [PubMed - indexed for MEDLINE]


Beyond IMDC: do expanded models improve survival discrimination in metastatic renal cell carcinoma? A real-world cohort study.
Front Oncol
, Gökmen A, Haf.
PMID: 42597456 [PubMed]


Immediate intraoperative detrusor muscle status at primary transurethral resection of bladder tumour: a prospective, blinded, paired cohort, feasibility study using fluorescence confocal microscopy (IB1-LaserComplete study).
BJU Int
Connor MJ, Gopalakrishnan A, Mayor N, Bolton E, Hamid S, Reddy SK, Perreau T, Maher E, Light A, Morris S, Jaipura J, Tanaka MB, Gibbons N, Hughes-Hallett A, Ahmed HU, Heer R, Smith A, Hrouda D, Silvanto A, El-Bahrawy M, Winkler M.
PMID: 42596073 [PubMed - as supplied by publisher]


Impact of MRI slice thickness and fiducial marker orientation on geometric accuracy in multi-echo GRE imaging for prostate radiotherapy planning.
J Appl Clin Med Phys
Hayashi A, Takahashi Y, Sanuki N, Yamashita Y, Suzuki Y, Matsuura K, Muto H.
PMID: 42596050 [PubMed - indexed for MEDLINE]


Efficacy of Olaparib Plus Abiraterone for Patients with Metastatic Castration-resistant Prostate Cancer and Single Homologous Recombination Repair Gene Mutations in PROpel.
Eur Urol Oncol
Shore N, Clarke NW, Armstrong AJ, Oya M, Procopio G, Guedes JD, Arslan C, Mehra N, Brown E, Joung JY, Sugimoto M, Vianna K, Hosius C, Barnicle A, Liu YZ, Harrington EA, Longworth D, Kang J, Saad F.
PMID: 42595654 [PubMed - as supplied by publisher]


Clinical Trial Protocol for LPS-Boost: Intensified [(177)Lu]Lu-PSMA-617 Treatment for Patients with Metastatic Castration-Resistant Prostate Cancer with Low PSMA-Expressing Disease.
J Nucl Med
Iravani A, Gulati R, Miyaoka R, Reiger AC, Chen DL, Kumar M, Erickson M, Nega K, Meyer C, Lira S, Seo Y, Flavell RR, Pritchard CC, Haffner MC, Nadal Rios R, Sunkara R, Khan HM, Yezefski T, Raychaudhuri R, Hsieh AC, Grivas P, Cheng HH, Yu EY, Schweizer MT, Nelson PS, Czernin J, Hope TA, Calais J.
PMID: 42595485 [PubMed - as supplied by publisher]


Solitary fibrous tumour mimicking a urethral caruncle: a diagnostic pitfall.
BMJ Case Rep
Ono Y, Miyazawa Y, Arai S, Sekine Y, Sugita K.
PMID: 42595384 [PubMed - indexed for MEDLINE]


ZEB1 orchestrates cellular plasticity and therapy resistance in prostate cancer: from molecular mechanisms to clinical targeting.
Crit Rev Oncol Hematol
Wang Q, Wang J, Zhao Y, Yan J, Zhang Y, Liu Z, Zhao Z, Yu H.
PMID: 42595197 [PubMed - as supplied by publisher]


Real-World Perioperative and Early Oncological Outcomes of Robot-Assisted Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Single-Institution Series of 100 Consecutive Patients.
Asian J Endosc Surg
Yajima S, Okumura G, Gozu S, Kataoka M, Nakanishi Y, Masuda H.
PMID: 42594915 [PubMed - indexed for MEDLINE]


Treatment and Outcomes of Patients With Metastatic Castration-resistant Prostate Cancer by Race, Initial Diagnosis, and Family History: Results From the TRUMPET Registry.
Clin Genitourin Cancer
Karsh L, Hwang C, Symanowski J, Shevrin D, Elsouda D, Russell D, Spalding J, Kral P, El-Chaar N, Shore N.
PMID: 42594809 [PubMed - as supplied by publisher]


PCaSFUA-Net: Spatial frequency collaboration and uncertainty-aware fusion for multimodal prostate cancer segmentation.
Comput Med Imaging Graph
Li C, Huang M, Li Y, Li Y, Zhang Y, Long H, Wang T, Bai Z.
PMID: 42594737 [PubMed - as supplied by publisher]


Raising Suspicion Rather than Making a Definitive Diagnosis of Rare Renal Tumor Subtypes.
Radiographics
Jinzaki M, Nicola R.
PMID: 42594024 [PubMed - in process]


Stereotactic Body Radiotherapy vs Moderately Hypofractionated IMRT for Localized Intermediate-Risk Prostate Cancer: A Randomized Clinical Trial.
JAMA
Ellis RJ, Pugh SL, Yu JB, Feng FY, Konski AA, Grubb RL 3rd, Wallace RE, Gladstone DJ, Ménard C, Miccio JA, Frazier AJ, Pennington JD, Michalski JM, Spratt DE, Martinez A, Morgan SC, Mihai A, Solanki AA, Amjad A, Straza MW, Delouya G, Schroeder TM, Marshall DT, Kapadia N, Patel AN, Cescon TP, El-Gayed A, Yoon HA, Paulus R, Sandler HM, NRG-GU005 Collaborative Authors.
PMID: 42593775 [PubMed - as supplied by publisher]


Positive surgical margins after partial nephrectomy across changing surgical eras: long-term oncological results from a tertiary referral center.
World J Urol
Bertini A, Re C, Salerno L, Musso G, Cei F, Rosiello G, Barretta A, Belladelli F, Piccolo C, Disabato N, Campugiani A, Montesano M, Ficarra G, Tenace N, Colecchia M, Ponzoni M, Cigliola A, Necchi A, Briganti A, Bertini R, Salonia A, Montorsi F, Larcher A, Capitanio U.
PMID: 42593572 [PubMed - indexed for MEDLINE]


Real-world treatment patterns and clinical outcomes in patients with non-muscle invasive bladder cancer: a nationwide evaluation.
World J Urol
Raskin Y, Baekelandt F, Decaestecker K, Seront E, Grisay G, De Sutter T, Bailly M, Noujeim JP, Maes H, De Smedt L, Waltregny D, Brochier W, Roumeguère T, Tombal B.
PMID: 42593560 [PubMed - indexed for MEDLINE]


The molecular underpinnings of the immune landscape in prostate cancer: decoding a "cold" tumor.
Front Oncol
Li K, Yang W, Huang D.
PMID: 42591989 [PubMed]


   
   Articles 1 - 20 / 180724    Page 1 of 9037  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1